Infectious Diseases and HIV Conference

The types of pulmonary infections include a wide variety of pathogens, such as bacteria, viruses, fungi, and mycobacteria. Major among these are CAP, HAP, and chronic conditions including tuberculosis.

Below is a discussion of the clinical impact of these infections, their epidemiology, and complications such as ARDS and chronic lung damage. Antimicrobial therapy and resistance challenges the core of treatment for pulmonary infection remains antimicrobial agents targeted to the causative pathogen.

Participants will review strategies regarding how antibiotics, antivirals, or antifungals best should be chosen by pathogen and patterns of susceptibility.

It will clearly elucidate how antimicrobial stewardship prevents resistance, and hence, addresses a growing concern: multiresistant tuberculosis and MRSA. All these will include novel treatment therapies for viral respiratory infections that also include influenza and COVID-19, including the newest antiviral therapies.

Newest Antiviral Therapies: Novel approaches to treatment, aside from conventional antimicrobial therapy, are being developed for better management of pulmonary infections. Some of these developments include targeted therapies- monoclonal antibodies for respiratory syncytial virus, host-directed therapies that modulate the immune response to infection, and aerosolized antibiotics and antivirals directly delivered into the lungs.

Complicated Cases Management: Pulmonary infection management in special populations: Such as COPD patients, cystic fibrosis patients, or immunocompromised subjects is challenging.

In this session, we will emphasize strategies for optimizing therapy in such cases, including individualized therapeutic strategies, use of combination therapy, and supportive measures.

Join us in an in-depth session with leading experts in this regard as we ponder the new horizon of therapy in pulmonary infection, improve, and relate this outcome with emerging challenges of caregiving for the respiratory system.